Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 3/20 | 0.46 |
| ▸ | NOS1 | P29475 | 3/20 | 0.46 |
| ▸ | NOS2 | P35228 | 2/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | ARG2 | P78540 | 1/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1072789 | 0.85 | MAOB (0.52) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL7376318 | 0.81 | MAOB (0.48) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL14363102 | 0.81 | MAOB (0.48) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL23644539 | 0.79 | MAOB (0.46) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL516688 | 0.79 | MAOB (0.46) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL9192371 | 0.79 | MAOB (0.46) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL902765 | 0.79 | MAOB (0.57) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL6948797 | 0.78 | MAOB (0.44) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL8517077 | 0.78 | MAOB (0.44) | MAOBIDO1NOS1NOS2NOS3 | |
| SCHEMBL6948801 | 0.78 | MAOB (0.44) | MAOBIDO1NOS1NOS2NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1986606-B1 | PHENYLEPHRINE-CONTAINING LIQUID FORMULATIONS | WYETH LLC (US) | 2019-04-10 | — | — | EP | claimed |
| US-20150182478-A1 | CHEWABLE TABLET CONTAINING PHENYLEPHRINE | WYETH CORP (US) | 2015-07-02 | — | — | US | claimed |
| US-20150150976-A1 | PHENYLEPHRINE-CONTAINING LIQUID FORMULATIONS | HALEON US HOLDINGS LLC | 2015-06-04 | — | — | US | claimed |
| US-8940796-B2 | Phenylephrine liquid formulations | WYETH LLC (US) | 2015-01-27 | — | — | US | claimed |
| EP-2351554-A1 | Enhanced stability phenylephrine liquid compositions | Wyeth LLC (US) | 2011-08-03 | — | — | EP | claimed |
| EP-2316425-A1 | Liquid formulations comprising an active agent, glycerine and sorbitol | Wyeth LLC (US) | 2011-05-04 | — | — | EP | claimed |
| CN-101505738-A | Chewable tablet containing phenylephrine | WYETH CORP (US) | 2009-08-12 | — | — | CN | claimed |
| EP-2043619-A2 | CHEWABLE TABLET CONTAINING PHENYLEPHRINE | Wyeth (US) | 2009-04-08 | — | — | EP | claimed |
| EP-2040672-A2 | ENHANCED STABILITY PHENYLEPHRINE LIQUID COMPOSITIONS | Wyeth (US) | 2009-04-01 | — | — | EP | claimed |
| EP-1986606-A2 | PHENYLEPHRINE-CONTAINING LIQUID FORMULATIONS | Wyeth a Corporation of the State of Delaware (US) | 2008-11-05 | — | — | EP | claimed |
| US-20080026055-A1 | Chewable tablet containing phenylephrine | WYETH (US) | 2008-01-31 | — | — | US | claimed |
| WO-2008013710-A2 | CHEWABLE TABLET CONTAINING PHENYLEPHRINE | WYETH (US) | 2008-01-31 | — | — | WO | claimed |
| US-20080014274-A1 | Enhanced stability phenylephrine liquid compositions | WYETH (US) | 2008-01-17 | — | — | US | claimed |
| WO-2008008364-A2 | ENHANCED STABILITY PHENYLEPHRINE LIQUID COMPOSITIONS | WYETH (US) | 2008-01-17 | — | — | WO | claimed |
| WO-2007098128-A2 | PHENYLEPHRINE-CONTAINING LIQUID FORMULATIONS | WYETH (US) | 2007-08-30 | — | — | WO | claimed |
| US-20070197661-A1 | Phenylephrine liquid formulations | WYETH (US) | 2007-08-23 | — | — | US | claimed |
| US-6955824-B1 | Inhalation composition containing lactose pellets | GLAXO GROUP LIMITED (GB) | 2005-10-18 | — | — | US | claimed |
| US-20200269668-A1 | Biologically Efficacious Compositions, Articles of Manufacture And Processes For Producing And/Or Using Same | VACHON DAVID JOHN (US) | 2020-08-27 | — | — | US | disclosed |
| US-20050266031-A1 | Pharmaceutical suspension composition | WYETH LLC | 2005-12-01 | — | — | US | disclosed |
| US-6077822-A | COMPRISING WATER-INSOLUBLE SALT OF MONO TO OCTA-SACCHARIDE SUGAR ACID WITH BIOLOGICALLY ACTIVE COMPOUND SELECTED FROM AMINOGLYCOSIDES, TETRACYCLINES, POLYPEPTIDES, GLYCOPEPTIDES AND MACROLIDES FOR CONTROLLED RELEASE OF DRUGS | DUMEX-ALPHARMA A/S (DK) | 2000-06-20 | — | — | US | disclosed |